Bausch & Lomb Corp SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account
Bausch & Lomb Corp (BLCO) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account of $1.56 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts · last filed 2026-07-29
- Bausch & Lomb Corp sec schedule, 12-09, valuation allowances and reserves, additions, charge to other account for the quarter ending 2026-06-30 was $808.00M, a 1.25% increase year-over-year.
- Bausch & Lomb Corp sec schedule, 12-09, valuation allowances and reserves, additions, charge to other account for the quarter ending 2026-03-31 was $753.00M, a 2.73% increase year-over-year.
- Bausch & Lomb Corp sec schedule, 12-09, valuation allowances and reserves, additions, charge to other account for the quarter ending 2025-12-31 was $945.00M, a 24.67% increase year-over-year.
- Bausch & Lomb Corp sec schedule, 12-09, valuation allowances and reserves, additions, charge to other account for the quarter ending 2025-09-30 was $837.00M, a 26.63% increase year-over-year.
- Bausch & Lomb Corp sec schedule, 12-09, valuation allowances and reserves, additions, charge to other account for fiscal 2025 was $3.31B, a 21.89% increase from fiscal 2024.
- Bausch & Lomb Corp sec schedule, 12-09, valuation allowances and reserves, additions, charge to other account for fiscal 2024 was $2.72B, a 53.73% increase from fiscal 2023.
- Bausch & Lomb Corp sec schedule, 12-09, valuation allowances and reserves, additions, charge to other account for fiscal 2023 was $1.77B, a 28.49% increase from fiscal 2022.
- Bausch & Lomb Corp sec schedule, 12-09, valuation allowances and reserves, additions, charge to other account for fiscal 2022 was $1.38B, a 7.84% increase from fiscal 2021.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account 3 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account 6 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account 9 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account 12 month |
|---|---|---|---|---|
| 2026-06-30 | $808.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.56B 10-Q · filed 2026-07-29 | $2.51B derived: sum of 3 quarters · filed 2026-07-29 | $3.34B derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $753.00M 10-Q · filed 2026-04-29 | $1.70B derived: sum of 2 quarters · filed 2026-04-29 | $2.54B derived: sum of 3 quarters · filed 2026-04-29 | $3.33B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $945.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $1.78B derived: sum of 2 quarters · filed 2026-02-18 | $2.58B derived: sum of 3 quarters · filed 2026-07-29 | $3.31B 10-K · filed 2026-02-18 |
| 2025-09-30 | $837.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.64B derived: sum of 2 quarters · filed 2026-07-29 | $2.37B 10-Q · filed 2025-10-29 | $3.13B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $798.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.53B 10-Q · filed 2026-07-29 | $2.29B derived: sum of 3 quarters · filed 2026-07-29 | $2.95B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $733.00M 10-Q · filed 2026-04-29 | $1.49B derived: sum of 2 quarters · filed 2026-04-29 | $2.15B derived: sum of 3 quarters · filed 2026-04-29 | $2.82B derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $758.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $1.42B derived: sum of 2 quarters · filed 2026-02-18 | $2.08B derived: sum of 3 quarters · filed 2026-02-18 | $2.72B 10-K · filed 2026-02-18 |
| 2024-09-30 | $661.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.33B derived: sum of 2 quarters · filed 2025-10-29 | $1.96B 10-Q · filed 2025-10-29 | $2.56B derived: sum of 4 quarters · filed 2025-10-29 |
| 2024-06-30 | $666.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $1.30B 10-Q · filed 2025-07-30 | $1.90B derived: sum of 3 quarters · filed 2025-07-30 | $2.29B derived: sum of 4 quarters · filed 2025-07-30 |
| 2024-03-31 | $633.00M 10-Q · filed 2025-04-30 | $1.24B derived: sum of 2 quarters · filed 2025-04-30 | $1.63B derived: sum of 3 quarters · filed 2025-04-30 | $2.05B derived: sum of 4 quarters · filed 2025-04-30 |
| 2023-12-31 | $603.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $993.00M derived: sum of 2 quarters · filed 2025-02-19 | $1.42B derived: sum of 3 quarters · filed 2025-02-19 | $1.77B 10-K · filed 2025-02-19 |
| 2023-09-30 | $390.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $814.00M derived: sum of 2 quarters · filed 2024-10-30 | $1.17B 10-Q · filed 2024-10-30 | $1.49B derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | $424.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $775.00M 10-Q · filed 2024-08-01 | $1.10B derived: sum of 3 quarters · filed 2024-08-01 | $1.46B derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $351.00M 10-Q · filed 2024-05-01 | $680.00M derived: sum of 2 quarters · filed 2024-05-01 | $1.04B derived: sum of 3 quarters · filed 2024-05-01 | $1.41B derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $329.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $689.00M derived: sum of 2 quarters · filed 2024-02-21 | $1.06B derived: sum of 3 quarters · filed 2024-02-21 | $1.38B 10-K · filed 2024-02-21 |
| 2022-09-30 | $360.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $727.00M derived: sum of 2 quarters · filed 2023-11-01 | $1.05B 10-Q · filed 2023-11-01 | $1.37B derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $367.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $687.00M 10-Q · filed 2023-08-02 | $1.01B derived: sum of 3 quarters · filed 2023-08-02 | $1.34B derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $320.00M 10-Q · filed 2023-05-03 | $643.00M derived: sum of 2 quarters · filed 2023-05-03 | $970.00M derived: sum of 3 quarters · filed 2023-05-03 | $1.31B derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | $323.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $650.00M derived: sum of 2 quarters · filed 2023-02-22 | $990.00M derived: sum of 3 quarters · filed 2023-02-22 | $1.28B 10-K · filed 2023-02-22 |
| 2021-09-30 | $327.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $667.00M derived: sum of 2 quarters · filed 2022-11-02 | $953.00M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $340.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $626.00M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $286.00M 10-Q · filed 2022-06-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B |